SAGE Therapeutics Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest SAGE Therapeutics' careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

**Overview** **General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for an important role that is responsible for the design and oversight of the nonclinical safety testing progr...
Posted: July 19, 2018, 8:22 am
**Overview** **Title: Head of Human Resources - Europe** **Reports to: SVP, People and Organizational Strategy** **General Scope and Summary** SAGE Therapeutics is searching for a creative, resourc...
Posted: July 18, 2018, 7:47 am
**Overview** **About this role:** As a key member of Sage Therapeutics’ Human Resources team, you will lead Talent Acquisition for Sage’s Research & Development efforts. As a company ambassador, you will be responsible for art...
Posted: July 18, 2018, 7:47 am
**Overview** **Summary** The Director, Patient Advocacy is responsible for supporting the head of patient advocacy in the development and pull through of Sage’s overarching advocacy strategy and for external engagement with multiple ...
Posted: July 17, 2018, 7:07 am
**Overview** **General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for an important role as the Associate Director, Clinical Data Management. This role is accountable for Data M...
Posted: July 17, 2018, 7:07 am

Viewing page 1 of 60|Next Page

  Newsfeed | Subscribe  

DUBLIN--(BUSINESS WIRE)--The "Equine Encephalitis - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. This report offers a comprehensive insight of the pipeli...
Posted: July 19, 2018, 11:04 am
Investors sentiment increased to 1.73 in Q1 2018. Its up 0.24, from 1.49 in 2017Q4. It improved, as 22 investors sold Sage Therapeutics, Inc. shares while 56 reduced holdings. 47 funds opened position...
Posted: July 12, 2018, 4:12 am
This morning, WallStEquities.com recalls the previous performance of RXi Pharmaceuticals Corp. (NASDAQ: RXII), Sage Therapeutics Inc. (NASDAQ: SAGE), Sangamo Therapeutics Inc. (NASDAQ: SGMO), and Vera...
Posted: July 6, 2018, 5:03 am
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on July 2, ...
Posted: July 5, 2018, 9:33 am
MarketIntelligenceCenter.com’s patented algorithms have chosen the Aug 17, 2018 $155 call for a couple of hedged-trading ideas on Sage Therapeutics (SAGE). A traditional covered call on Sage Therapeut...
Posted: July 2, 2018, 1:00 am

Viewing page 1 of 3|Next Page